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Abstract
Background: Hypertension, the leading single cause of morbidity and mortality worldwide, is a growing public
health problem in sub-Saharan Africa (SSA). Few studies have estimated and compared the burden of hypertension
across different SSA populations. We conducted a cross-sectional analysis of blood pressure data collected through
a cohort study in four SSA countries, to estimate the prevalence of pre-hypertension, the prevalence of hypertension,
and to identify the factors associated with hypertension.
Methods: Participants were from five different population groups defined by occupation and degree of urbanization,
including rural and peri-urban residents in Uganda, school teachers in South Africa and Tanzania, and nurses in Nigeria.
We used a standardized questionnaire to collect data on demographic and behavioral characteristics, injuries, and
history of diagnoses of chronic diseases and mental health. We also made physical measurements (weight, height and
blood pressure), as well as biochemical measurements; which followed standardized protocols across the country sites.
Modified Poison regression modelling was used to estimate prevalence ratios (PR) as measures of association between
potential risk factors and hypertension.
Results: The overall age-standardized prevalence of hypertension among the 1216 participants was 25.9 %.
Prevalence was highest among nurses with an age-standardized prevalence (ASP) of 25.8 %, followed by
school teachers (ASP = 23.2 %), peri-urban residents (ASP = 20.5 %) and lowest among rural residents (ASP = 8.7 %).
Only 50.0 % of participants with hypertension were aware of their raised blood pressure. The overall age-standardized
prevalence of pre-hypertension was 21.0 %. Factors found to be associated with hypertension were: population group,
older age, higher body mass index, higher fasting plasma glucose level, lower level of education, and tobacco use.
Conclusions: The prevalence of hypertension and pre-hypertension are high, and differ by population group defined
by occupation and degree of urbanization. Only half of the populations with hypertension are aware of their
hypertension, indicating a high burden of undiagnosed and un-controlled high blood pressure in these populations.
Keywords: Prevalence of hypertension, Prevalence of pre-hypertension, Sub-Saharan Africa, Risk factors for
hypertension, Chronic disease epidemiology
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Background
Hypertension, the most common cardiovascular disorder
affecting approximately one billion people globally, re-
mains the leading single contributor to global burden of
disease and mortality accounting for approximately 9.4
million deaths annually [1–5]. In 2000, there were an es-
timated 972 million people with hypertension, 65 % of
whom lived in the developing world, with the number
predicted to grow to 1.5 billion by 2025. The effects of
hypertension if not controlled are devastating, and may
include stroke, myocardial infarction, cardiac failure, and
renal failure among others [6].
A number of studies indicate that hypertension in sub-
Sahara Africa (SSA) is a widespread problem, and in
some communities it has been reported to be as high as
38 % [4, 7–9]. It is estimated that out of the approxi-
mately 650 million people in SSA, between 10 to 20
million may have hypertension [7]. However many coun-
tries in SSA still lack detailed basic data on the preva-
lence of hypertension [3], and how this is distributed in
the different SSA populations. Further, few studies have
reported on the proportion of persons with hypertension
who are aware of their hypertension, and the burden of
pre-hypertension. We analyzed data collected through a
cohort study conducted by the Partnership for Cohort
Research and Training (PaCT) consortium, in four sub-
Saharan countries including Nigeria, South Africa, Tanzania
and Uganda [10]; to estimate the prevalence of hyper-
tension and pre-hypertension, and to identify factors
associated with hypertension.
Methods
A detailed description of methods used in the parent
PaCT study from which this analysis is derived has been
reported elsewhere [10]. Here we only describe methods
relevant to results presented in this article.
Study design
The parent study was conducted using a cohort study
design between January 2011 and July 2012. Partici-
pants were followed for up to six months, with evalua-
tions at baseline, and at six months only. Results
presented in this article are a cross-sectional analysis
of the baseline data.
Study population
The study was conducted in four sub-Saharan countries,
including Tanzania, South Africa, Uganda and Nigeria.
Participants were enrolled from 5 different population
groups, three defined by occupation, and two by degree
of urbanization. Tanzania and South Africa enrolled
school teachers, Nigeria enrolled nurses, whereas
Uganda enrolled rural and peri-urban residents. Eligible
subjects were adults aged 18 years or older, with no
intension of migrating outside of their community of
residence within the next 6 months (in Uganda), or retir-
ing from service in the next 6 months (for Tanzania,
South Africa and Nigeria).
School teachers in Tanzania were enrolled from 18
randomly selected public schools in Dar es Salaam. In
South Africa, school teachers were enrolled from gov-
ernment schools in Cape Town Metropolitan area,
where 111 schools with 20 or more teachers were invited
to participate in the study. In Nigeria, a random sample
of nurses were enrolled from two urban hospitals; one
located in Abuja city and another in a semi-urban set-
ting 1.5 h outside of Abuja city. In Uganda, participants
were enrolled from two geographic locations; a peri-urban
community in the Wakiso District 10 miles north of
Kampala city, and from a rural community in Bushenyi
District 200 miles west of Kampala city. In Wakiso
District, a random sample of households was selected
from two parishes comprising 13 villages. In Bushenyi
District, households were randomly selected from an enu-
merated list of all the households in each village.
Ethics, consent and permissions
Informed consent was obtained from each subject either
by voluntarily posting back a signed form with a com-
pleted questionnaire (South Africa and Tanzania) or
through documentation with trained interviewers
(Nigeria and Uganda). The pilot studies were approved
by the: a) Harvard School of Public Health Institutional
Review Board, b) Institute of Human Virology Heath Re-
search Ethics Committee in Nigeria; c) Health Research
Ethics Committee of the Faculty of Health Sciences,
Stellenbosch University in South Africa; d) National In-
stitute for Medical Research in Tanzania; and in
Uganda; e) Makerere University School of Public Health
Higher Degrees, Research and Ethics Committee; f )
Mbarara University of Science and Technology Ethics
Committee, and g) the Uganda National Council of
Science and Technology.
Measurements
We used a standardized questionnaire to collect data on
socio-economic characteristics, history of infectious and
chronic disease diagnoses, mental health, injuries, and
common risk factors for non-communicable diseases
(NCDs) including tobacco use, alcohol use, and physical
activity. Most of the questions were adapted from the
World Health Organization STEPS instrument devel-
oped for use in resource-limited countries [11]. Physical
and biochemical measurements were also made follow-
ing a standardized protocol across the five study sites.
Physical measurements included weight, height, and
blood pressure. Height was measured without shoes, to
the nearest centimetre. Weight was measured with the
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participants in light clothing and without footwear using
a weighing scale to the nearest tenth of a kilogram.
Blood pressure measurements were taken on the left
arm with the participant in the sitting position using a
cali-brated electronic blood pressure device (Welch-
Allyn®). Three systolic and diastolic blood pressure mea-
surements were taken at least five minutes apart. The
average of the last two blood pressure readings was used
in this analysis.
After administering the questionnaire, interviewers re-
quested participants for an appointment to return the
following morning so that a blood sample could be ob-
tained to measure plasma glucose levels. Participants
were instructed to fast overnight and no exercise or
smoking in the morning, in preparation for obtaining a
blood sample to conduct a fasting plasma glucose (FPG)
measurements. The following morning the interviewer
returned and collected the participant’s finger prick
blood sample for an FPG test using a digital glucometer
(On-Call® Plus, ACON Laboratories). Only participants
reporting compliance with an overnight 8-h fast, no ex-
ercise or smoking that morning were eligible for the fin-
ger prick blood sample collection. Non-compliers were
rescheduled to a future date where possible; otherwise
this procedure was omitted in such participants. FPG
levels were recorded in milli moles per liter (mmol/L).
Statistical analysis
Participants were classified in different blood pressure
categories based on the World Health Organization
(WHO) cut-off criteria [12, 13]. Thus a participant was
classified as being hypertensive if their average systolic
blood pressure (SBP) was at least 140 mm Hg, and/or
their average diastolic blood pressure (DBP) was at least
90 mm Hg, or if they reported being on regular anti-
hypertensive therapy. A participant was classified as be-
ing pre-hypertensive if their average SBP was between
120 and 139 mm Hg (inclusive), and/or their DBP was
between 80 and 89 mm Hg (inclusive), and not on any
anti-hypertensive therapy.
The prevalence of pre-hypertension and hypertension
were calculated as the percentage of participants classi-
fied as being pre-hypertensive or hypertensive, respect-
ively. To enable comparison of prevalence across the five
population groups with differing age-structures, preva-
lence was directly age-standardized to the World Health
Organization’s 2000–2025 world standard population
age structure [14, 15].
Body Mass Index (BMI) was computed by dividing the
weight (kg) by the height in meters squared (m2) and
used to develop the categories of: underweight (less or
equal to 18.5), normal weight (18.5–24.9), overweight
(25.0–29.9), and obese (30 or higher). Participants were
also categorized on the basis of their plasma glucose
levels status using the WHO definition and diagnosis of
diabetes mellitus criteria as follows: Normal (less than
6.1 mmol/L), Pre-diabetes (6.1 to 6.9 mmol/L), and dia-
betes or probable diabetes (greater than 6.9 mmol/L, or
currently on anti-diabetes mellitus medication) [16].
To identify factors associated with hypertension, the
modified Poisson regression model with robust variance
was used to estimate both the crude and adjusted preva-
lence ratios (PR) [17, 18], with their corresponding 95 %
confidence intervals (95 % CI). The modified Poisson re-
gression model, a model that uses a robust error vari-
ance, was preferred to avoid under estimation of the
standard errors for the estimated risk ratios that is usu-
ally the case with logistic regression modelling when the
prevalence of the outcome is greater than 10 % [17, 18].
Potential confounding and interaction variables that
were assessed for inclusion in the model were: age, sex,
level of education, body mass index, population group,
FPG category, family history of hypertension (first de-
gree relatives only), whether the participant met the
WHO physical activity recommendations [19], and to-
bacco use category. A step-by-step backward elimination
of these variables from the model was used to identify
those to be retained in the model. The criterion used to
retain variables in the model were if a variable was sig-
nificantly associated with hypertension using a 5 % level
of statistical significance (α = 0.05), or if addition of the
variable in the model led to a change of at least 10 % in
any of the significant PR estimates of any variable
already in the model. Cases with missing observations
were excluding from the model on a case by case basis.
All statistical analyses were performed using STATA
version 13 (StataCorp, College Station, Texas, USA).
Results
Study participants
A total of 1414 subjects participated in the baseline cohort
pilot study. Of the 1414 participants, at least two blood
pressure measurements were available from 1269 (89.7 %)
participants and were used in this analysis. These included
163 nurses in Nigeria, 477 school teachers in South Africa,
167 school teachers in Tanzania, and from Uganda 297
peri-urban and 165 rural residents.
Of the 1269 participants, 820 (64.6 %) were females,
671 (52.9 %) were aged 30 to 49 years, and 879 (69.3 %)
had received up to secondary school education or at
least 8 years of schooling. The majority of participants
(772 or 60.8 %) were over-weight with a body mass
index (BMI) of 25 kilograms per squared meter (kg/m2)
or higher, including the 407 (32.1 %) that were obese
(BMI ≥ 30 kg/m2). Of the participants, 121 (9.5 %) re-
ported current use of some form of tobacco and only
272 (21.4 %) reported physical activity levels that meet
the WHO recommendation of at least 75 min of
Guwatudde et al. BMC Public Health  (2015) 15:1211 Page 3 of 8
vigorous-intensity or 150 min of moderate-intensity
physical activity per week [19]. The rest of characteris-
tics of the participants are presented in Table 1.
Prevalence of hypertension and pre-hypertension
Of the 1269 participants, 468 were classified as being
hypertensive giving an overall crude prevalence of
36.9 %. The overall age-adjusted prevalence was
25.9 %. Hypertension was highest amongst nurses in
Nigeria with age-adjusted prevalence of 25.8 %, followed
by school teachers in South Africa with age-adjusted
prevalence of 23.2 %, then by school teachers in Tanzania
with age-adjusted prevalence of 23.1 %, whereas the peri-
urban and rural residents in Uganda had an age-adjusted
prevalence of 20.5 % and 8.7 %, respectively (Table 2).
Only 234 of the 468 participants with hypertension
(50.0 %), were aware of their raised blood pressure con-
dition. The level of awareness varied significantly by
population group (p < 0.001), being highest among
nurses in Nigeria at 77.9 %, and lowest among rural resi-
dents in Uganda at 14.3 %. Figure 1 shows the percent-
age of participants with hypertension who were aware of
their raised blood pressure status, by population group.
A total of 378 participants were classified as being
pre-hypertensive, giving a crude prevalence of 29.8 %,
and an overall age-adjusted prevalence of 21.0 %. Pre-
hypertension was highest among school teachers in
South Africa with an age-adjusted prevalence of 26.0 %,
followed by peri-urban and rural residents in Uganda
with age-adjusted prevalence of 21.6 % and 19.5 % re-
spectively, followed by nurses in Nigeria and school
teachers in Tanzania with age-adjusted prevalence of
16.3 % and 7.5 %, respectively (Table 2).
Factors associated with hypertension
Factors found to be associated with hypertension in-
cluded population group, age, body mass index, fasting
plasma glucose (FPG), level of education, and tobacco
use. Compared to the rural residents in Uganda, the
prevalence of hypertension was highest among nurses in
Nigeria with an adjusted prevalence ratio (PR) of 6.49
[95 % CI = 2.26 – 18.7]. The prevalence of hypertension
was significantly higher among participants aged 50 years
or older compared to those aged 18 – 29 years with an
adjusted PR of 2.20 [95 % CI = 1.49 – 3.25]. We found a
significantly lower adjusted prevalence among partici-
pants who attained secondary school level of education
compared to those reporting no formal education, with
a PR of 0.54 [95 % CI = 0.31 – 0.93]. We also the preva-
lence of hypertension to be significantly higher among
participants with BMI between 25 to 29.9 kg/m2 com-
pared to those with BMI less than 25, with an adjusted
PR = 1.61 [95 % CI = 1.18 – 2.20], and even higher
among the obese (BMI ≥ 30 kg/m2) participants com-
pared to those with BMI less than 25 with an adjusted
PR = 2.11 [95 % CI = 1.56 – 2.84]. The prevalence of
hypertension was also more likely to be higher among
participants with fasting plasma glucose (FPG) of
7.0 mmol/L or higher, compared to those with FPG less
than 6.1 mmol/L, with an adjusted PR of 1.38 [95 % CI =
1.10 – 1 171]. Finally, the prevalence of hypertension was
Table 1 Participant characteristics
Characteristic - n - Percentage
Population group Rural residents 165 13.0 %
Peri-urban residents 297 23.4 %
School teachers, Tanzania 167 13.2 %
Nurses, Nigeria 163 12.8 %
School teachers, South Africa 477 37.6 %
Sex: Males 449 35.4 %
Females 820 64.6 %
Age in years: 18–29 231 18.2 %
30–39 287 22.6 %
40–49 384 30.3 %
≥50 314 24.7 %
Not stated 53 4.2 %








University 516 40.6 %
Not stated 71 5.6 %
Marital status: Never married 436 34.4 %
Married/Co-habiting 655 51.6 %
Separated/divorced 100 7.9 %
Other 51 4.0 %
Not stated 27 2.1 %
Family history of HPTa No 869 68.5 %
Yes 400 31.5 %
Body mass index
(kg/m2)
<18.5 23 1.8 %
18.5–24.9 386 30.4 %
25.0–29.9 365 28.8 %
≥30.0 407 32.1 %
Not stated 71 5.6 %
Tobacco use type: Never 842 66.4 %
Stopped 104 8.2 %
Current user 121 9.5 %
Not stated 202 15.9 %
aHPT Hypertension
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significantly higher among participants reporting to use
unfiltered tobacco, compared to those reporting to
had never used tobacco, with an adjusted PR of 1.7
[1.04 – 2.91] (Table 3).
Discussion
In this study we found the overall age-standardized
prevalence of hypertension to be high in the population
groups studied, at nearly 26 %. Prevalence varied signifi-
cantly by population group defined by occupation, and
degree of urbanization, from rural to peri-urban resi-
dents, and between school teachers and nurses that were
from urban centers. Our findings clearly demonstrate
the urban–rural divide of the burden of hypertension in
sub-Saharan Africa that has been highlighted by others
[3, 7, 20]. Surprising was the finding that prevalence was
highest among the health care workers - nurses in Nigeria.
The astoundingly high prevalence of hypertension signals
an enormous future burden of hypertension-related
NCDs. The variation by population groups also suggests
that it might be more cost effective to design interventions
that target specific population groups with higher burden
of hypertension. Thus larger and more inclusive studies
are needed to identify population groups with higher bur-
den of hypertension.
We also found that overall, only 50 % of persons with
hypertension were aware of their hypertension, demon-
strating the high burden of undiagnosed and untreated
hypertension in SSA, a problem that has been highlighted
by others [3, 4, 21–23]. The complications of uncontrolled
blood pressure are devastating and include a number of
hypertension-related NCDs like myocardial infarction,
stroke, chronic kidney disease, and renal failure all of
which may be life threatening [24]. The high burden of
undiagnosed and untreated hypertension also signals the
need to increase detection rates of existing hypertension
and provide resources for adequate treatment [4, 23].
We also found a high age-standardized prevalence of
pre-hypertension at 21 %, which also varied significantly by
population group. It is recognised that persons with pre-
hypertension are at higher risk of progressing to hyperten-
sion, and becoming prone to hypertension-associated
cardiovascular diseases [12, 25, 26]. In fact Vasan et al.
(2001) estimated a 30 % conversion rate from pre-
hypertension state to hypertension every four years [27].
Risk reduction interventions aimed at preventing persons
with pre-hypertension progressing to hypertension are
Table 2 Prevalence of hypertension and pre-hypertension by population group
Characteristic Hypertension Pre-hypertension
- n - Crude Age-standardized Crude Age-standardized
All participants 1269 468 (36.8 %) 25.9 % 378 (29.8 %) 21.0 %
Rural residents, Uganda 165 21 (12.7 %) 8.7 % 55 (33.3 %) 19.5 %
Peri-urban residents, Uganda 297 70 (23.6 %) 20.5 % 97 (32.7 %) 21.6 %
Nurses, Nigeria 163 77 (47.2 %) 25.8 % 34 (20.9 %) 16.3 %
School teachers, South Africa 477 228 (47.8 %) 23.2 % 166 (34.8 %) 26.0 %
School teachers, Tanzania 167 72 (43.1 %) 23.1 % 26 (15.6 %) 7.5 %
Fig. 1 Percentage of participants with hypertension who are aware of their high blood pressure
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Table 3 Crude and adjusted prevalence ratio (PR) estimates for hypertension
Variable - n - # Hypertensive (%) Crude PR [95 % CI] Adjusted PRb [95 % CI]
Population group:
Rural residents 165 21 (12.7 %) 1.0 1.0
Peri-urban residents 298 70 (23.5 %) 1.85 [1.18–2.90] 2.28 [1.38–3.76]
School teachers, Tanzania 168 72 (42.9 %) 3.39 [2.19–5.24] 3.96 [2.22–7.06]
Nurses, Nigeria 163 77 (47.2 %) 3.71 [2.41–5.71] 6.49 [2.26–18.7]
School teachers, South Africa 478 229 (47.9 %) 3.76 [2.49–5.66] 2.91 [1.56–5.45]
Sex:
Males 451 146 (32.4 %) 1.0 1.0
Females 821 323 (39.3 %) 1.21 [1.04–1.43] 0.94 [0.76–1.17]
Age (years):
18–29 215 40 (18.6 %) 1.0 1.0
30–39 294 80 (27.2 %) 1.53 [1.10–2.13] 1.00 [0.65–1.53]
40–49 385 147 (38.2 %) 2.11 [1.56–2.85] 1.28 [0.84–1.95]
≥50 319 186 (58.3 %) 3.22 [2.41–4.30] 2.20 [1.49–3.25]
Level of education
None 49 15 (30.6 %) 1.0 1.0
Primary not completed 143 28 (19.6 %) 0.64 [0.38–1.10] 0.81 [0.46–1.43]
Primary completed 87 21 (24.1 %) 0.79 [0.45–1.38] 0.62 [0.33–1.17]
Secondary school 406 137 (33.7 %) 1.10 [0.71–1.72] 0.54 [0.31–0.93]
University or higher 516 229 (44.4 %) 1.46 [0.93–2.21] 0.56 [0.30–1.05]
Family history of hypertension:
No 871 290 (33.3 %) 1.0 1.0
Yes 401 179 (44.6 %) 1.3 [1.15–1.54] 1.21 [0.96–1.52]
Body mass index (kg/m2):
<25.0 409 83 (20.3 %) 1.0 1.0
25.0–29.9 367 131 (35.7 %) 1.78 [1.40–2.25] 1.61 [1.18–2.20]
≥30.0 407 210 (51.6 %) 2.59 [2.09–3.21] 2.11 [1.56–2.84]
FPGc/DMd category:
<6.1 603 168 (27.9 %) 1.0 1.0
6.1–6.9 103 28 (27.2 %) 0.92 [0.66–1.27] 0.91 [0.64–1.30]
≥7.0, or on DMd Rx 135 80 (59.3 %) 1.94 [1.62–2.31] 1.38 [1.10–1.71]
Met WHOe physical activity recommednations?
No 1.0 1.0
Yes 0.60 [0.48–0.75] 2.48 [0.34–18.0]
Tobacco used:
Never 845 274 (32.4 %) 1.0 1.0
Stopped 104 42 (40.4 %) 1.25 [0.97–1.60] 0.98 [0.73–1.31]
Filtered 98 45 (45.9 %) 1.42 [1.12–1.79] 1.21 [0.91–1.60]
Unfiltered 23 8 (34.8) 1.07 [0.61–1.89] 1.74 [1.04–2.91]
bAdjusted for Population group, Age, Level of education, BMI, FPG and Tobacco use
cFPG Fasting Plasma Glucose (mmol/L)
dDM Diabetes Mellitus
eWHO World Health Organization
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urgently needed to contribute to the overall reduction in
the prevalence of hypertension in SSA.
The factors we found to be associated with hyper-
tension in this study included population group, age,
BMI, level of education, and tobacco use. Most of
these have previously been identified some of the im-
portant risk factors for hypertension by the different
studies conducted in different parts of SSA [3, 28–31].
However we recognize that perhaps because of the
small sample size in our study, we were unable to dis-
entangle the various determinants of hypertension in
the population groups studied that may include
urban/rural, high/low social economic status as de-
fined by occupation, education, and country-specific
gross level of income, and potential regional differ-
ences due to ethnicity/genetics, and other shared but
unmeasured risk factors that may include stress, diet,
etc. Thus substantial variation in the prevalence of
hypertension remained in the multi-variable analysis.
This variation seems to have at least two important
consequences. The first is that it would be inconsider-
ate to make estimates for SSA based on small and ar-
bitrary selected samples. Thus our findings can only
be generalized to similar population groups included
in our analysis, not to the whole SSA populations. Sec-
ondly, the fact that a six-fold variation for one of the
population groups remained even in the multi-variable
analysis (nurses in Nigeria), indicates that there must
be other risk factors of fundamental importance for
hypertension other than those analyzed here. Thus
larger investigative studies of the type that PaCT
represents are needed in SSA to tease these out.
Conclusions
There are three key messages from this analysis:
a) The prevalence of hypertension is high at 25.9 %,
but differed significantly by population group
defined by occupation and degree of urbanization.
Interventions prioritizing higher prevalence
population groups might be more effective in
controlling hypertension in the population.
b) Fifty percent of persons with hypertension are
unaware of their hypertension, demonstrating a
high burden of undiagnosed and uncontrolled
hypertension, and signalling the need to increase
detection rates of existing hypertension and provide
resources for adequate treatment
c) Pre-hypertension is also high at 21 %, an indicator of
an enormous future burden of hypertension-related
non-communicable diseases (NCDs) if no appropriate
interventions are implemented. Interventions aimed at
preventing persons with pre-hypertension progressing
to hypertension are urgently needed.
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